These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6089861)

  • 1. Absence of prolactin receptors in normal and malignant uterine cervix.
    Dowsett M; McGarrick GE; Staffurth J; Worth RW; Chapman MG; Jeffcoate SL
    Br J Obstet Gynaecol; 1984 Sep; 91(9):924-6. PubMed ID: 6089861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of prolactin in carcinoma of the cervix.
    Macfee MS; McQueen J; Strayer DE
    Gynecol Oncol; 1987 Mar; 26(3):314-8. PubMed ID: 3549475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies in lipid composition of various subcellular fractions obtained from human normal and malignant "cervix uteri".
    Bhattacharyya M; Basu J; Roy SC
    Indian J Cancer; 1976 Mar; 13(1-3E760611-761022-3):51-6. PubMed ID: 965025
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study on estrogen and progesterone receptors in the human cervix and cervical squamous carcinoma].
    Yang ZR; Cao ZY
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):283-6, 317-8. PubMed ID: 3250810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of protein thiols in normal, dysplastic and atypical cervical cells (proceedings)].
    Bajardi F; Schauenstein E; Nöhammer G; Unger-Ullmann C
    Arch Gynakol; 1977 Jul; 224(1-4):525-6. PubMed ID: 579944
    [No Abstract]   [Full Text] [Related]  

  • 6. Basement membrane of the uterine cervix: immunofluorescence characteristics of the collagen component in normal or atypical epithelium and invasive carcinoma.
    Frappart L; Berger G; Grimaud JA; Chevalier M; Bremond A; Rochet Y; Feroldi J
    Gynecol Oncol; 1982 Feb; 13(1):58-66. PubMed ID: 7037565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytochemical determination of the protein sulfhydryl groups in the normal squamous epithelium, in erosion and in squamous cell carcinoma of the uterine cervix].
    Tolmachev VS
    Vopr Onkol; 1974; 20(8):17-21. PubMed ID: 4428640
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantification of protein thiols in normal and pathological cells of the epithelium of the portio uteri.
    Bajardi F; Schauenstein E; Nöhammer G; Unger-Ullmann C
    Acta Cytol; 1977; 21(4):573-7. PubMed ID: 269611
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytophotometric determination of DNA in minimal invasive cancer of the human cervix uteri.
    Herzog RE; Ciprian C
    Gynecol Obstet Invest; 1983; 15(5):261-5. PubMed ID: 6682822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytological distribution of the tumor antigen TA-4: expression during carcinogenesis and maturation of squamous epithelium of human uterine cervix.
    Hoshina M; Kimura A; Shibata K; Maruo T; Mochizuki M
    Asia Oceania J Obstet Gynaecol; 1986 Mar; 12(1):119-26. PubMed ID: 3521565
    [No Abstract]   [Full Text] [Related]  

  • 12. Electron spin resonance studies on normal human uterus and cervix and on benign and malignant uterine tumors.
    Benedetto C; Bocci A; Dianzani MU; Ghiringhello B; Slater TF; Tomasi A; Vannini V
    Cancer Res; 1981 Jul; 41(7):2936-42. PubMed ID: 6265070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and 3-methylcholanthrene induced cervical carcinoma. Effect of bromocriptine.
    Forsberg JG; Breistein LS
    Acta Pathol Microbiol Scand A; 1979 May; 87A(3):151-6. PubMed ID: 463562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies in lipids of human normal & malignant cervix uteri. I. Lipid content & composition of whole tissue & subcellular fractions.
    Ray TK; Roy SC
    Indian J Biochem; 1966 Jun; 3(2):106-10. PubMed ID: 4225697
    [No Abstract]   [Full Text] [Related]  

  • 15. Ectopic production of prolactin in uterine cervical carcinoma.
    Hsu CT; Yu MH; Lee CY; Jong HL; Yeh MY
    Gynecol Oncol; 1992 Feb; 44(2):166-71. PubMed ID: 1544594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
    Nishiya I; Ishizaki Y; Sasaki M
    Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA content in cervical cancer cells].
    Avtandilov GG; Kasab'ian SS; Sgibneva OV
    Vopr Onkol; 1974; 20(8):14-7. PubMed ID: 4428639
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of glycogen studies in the evaluation of treatment for carcinoma of the cervix uteri.
    Das DK; Chowdury JR
    Acta Cytol; 1981; 25(5):566-71. PubMed ID: 6945022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence and characterization of prolactin receptors in human benign breast tumours.
    Di Carlo R; Muccioli G; Bellussi G; Lando D; Mussa A
    Eur J Cancer Clin Oncol; 1984 May; 20(5):635-8. PubMed ID: 6145592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of low molecular weight cytokeratin proteins in cervical neoplasia.
    Bobrow LG; Makin CA; Law S; Bodmer WF
    J Pathol; 1986 Feb; 148(2):135-40. PubMed ID: 2419530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.